Pinnock Scarlett B, Balendra Rubika, Chan Melanie, Hunt Laurence T, Turner-Stokes Tabitha, Herbert Joe
Department of Physiology, Development and Neuroscience and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK.
Neuropsychopharmacology. 2007 Feb;32(2):493-504. doi: 10.1038/sj.npp.1301245. Epub 2006 Nov 1.
It is well established that L-NAME, a generic NOS inhibitor, stimulates neurogenesis in the dentate gyrus of the adult rat and corticosterone reduces it. These experiments explore the interaction between L-NAME and corticosterone. L-NAME (50 mg/kg), as expected, increased proliferation, but also lowered plasma corticosterone levels. However, the stimulating action of L-NAME depends on the presence of rhythmic changes in plasma corticosterone, as it is abolished in rats treated with a subcutaneous implant of corticosterone, which flattens the diurnal rhythm. Adrenalectomized rats implanted with corticosterone also failed to respond to L-NAME. Giving them a single daily injection of corticosterone (2 mg/kg) in an attempt to replicate the diurnal rhythm restored the sensitivity of the progenitor cells to L-NAME. The mechanism for this result remains to be investigated. Excess corticosterone given by daily injection (40/mg/kg) reduced proliferation but did not alter the response to L-NAME, even though this occurred from a lower baseline. nNOS was demonstrable only in the inner (proliferative) layer of the dentate gyrus in control rats, and did not alter following excess corticosterone treatment. iNOS was detectable at low levels in control rats, but was increased markedly following corticosterone. eNOS was evident throughout the dentate gyrus, and also increased after corticosterone (particularly in the hilus). Aminoguanidine (100 mg/kg/day; an iNOS antagonist) significantly increased proliferation in corticosterone-treated rats (40 mg/kg/day) but not in controls without additional corticosterone, confirming that iNOS plays a role in corticosterone-regulated neurogenesis. Corticosterone may thus act on progenitor cells in part at least through increased nitric oxide (NO) formation. The effects of reduced NO on neurogenesis may rely on a dual mechanism: corresponding reductions in plasma corticosterone and increased induction of iNOS (and/or eNOS) within the dentate gyrus. The possibility that NO acts downstream of glucocorticoids in the dentate gyrus is suggested.
众所周知,L-NAME(一种通用的一氧化氮合酶抑制剂)可刺激成年大鼠齿状回中的神经发生,而皮质酮则会抑制这种作用。这些实验探究了L-NAME与皮质酮之间的相互作用。正如预期的那样,L-NAME(50毫克/千克)增加了细胞增殖,但同时也降低了血浆皮质酮水平。然而,L-NAME的刺激作用取决于血浆皮质酮的节律性变化,因为在用皮下植入皮质酮使昼夜节律变平的大鼠中,这种作用被消除了。植入皮质酮的肾上腺切除大鼠对L-NAME也没有反应。为了重现昼夜节律,给它们每日注射一次皮质酮(2毫克/千克),这恢复了祖细胞对L-NAME的敏感性。这一结果的机制仍有待研究。每日注射过量的皮质酮(40毫克/千克)会减少细胞增殖,但不会改变对L-NAME的反应,尽管这是在较低的基线水平上发生的。在对照大鼠中,nNOS仅在齿状回的内层(增殖层)中可检测到,在过量皮质酮处理后没有改变。在对照大鼠中,iNOS的水平较低,但在皮质酮处理后显著增加。eNOS在整个齿状回中都很明显,在皮质酮处理后也增加了(特别是在齿状回门区)。氨基胍(100毫克/千克/天;一种iNOS拮抗剂)显著增加了皮质酮处理的大鼠(40毫克/千克/天)中的细胞增殖,但在没有额外皮质酮的对照大鼠中没有增加,证实了iNOS在皮质酮调节的神经发生中起作用。因此,皮质酮可能至少部分地通过增加一氧化氮(NO)的形成作用于祖细胞。NO减少对神经发生的影响可能依赖于双重机制:血浆皮质酮相应减少以及齿状回内iNOS(和/或eNOS)诱导增加。这表明NO可能在齿状回中糖皮质激素的下游起作用。